Novavax, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Novavax, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Novavax, Inc. stocks after a simple registration process. </div>

Q: How to buy Novavax, Inc. shares in India?

<div> To buy Novavax, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Novavax, Inc. and you are done!</div> </div>

Q: What is the share price of Novavax, Inc.?

<div>The share price of Novavax, Inc. is USD 4.71 as on 2 May.</div>

Q: What is the Market Capitalization of Novavax, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Novavax, Inc. is USD 661.3M as on 2 May.</div>

Q: What is the PE ratio of Novavax, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Novavax, Inc. is -1.20 as on 2 May. </div>

Q: Is Novavax, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Novavax, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Novavax, Inc. operate?

<div> Novavax, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$4.71

+0.04

(2 May)

Loading Chart

Previous close

$4.71

Open

$4.71

Today’s high

$4.78

Today’s low

$4.60

52W low

$3.53

52W high

$11.36

-33.02%

-14.87%

-1.20

EPS (TTM)

-5.41

Shares O/S

140.40M

Market cap

661.3M

Insights

NVAX is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Novavax, Inc.

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine).

The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response. .

FAQs

Can I buy Novavax, Inc. shares in India?

How to buy Novavax, Inc. shares in India?

What is the share price of Novavax, Inc.?

What is the Market Capitalization of Novavax, Inc.?

What is the PE ratio of Novavax, Inc.?

Is Novavax, Inc. a good stock to buy?

In which sector / industry does Novavax, Inc. operate?